Last reviewed · How we verify
NCT05792839
Abdominoplasty with Ventral Hernia Repair Versus Hernioplasty .
NA trial testing Abdominoplasty with ventral hernia repair versus ventral hernioplasty. in Abdominal Hernia in 52 participants. Not yet recruiting.
1 March 2025
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 52 |
| Start date | 1 March 2025 |
| Primary completion | 1 March 2025 |
| Estimated completion | 1 October 2025 |
Drugs / interventions tested
- Abdominoplasty with ventral hernia repair versus ventral hernioplasty.
Conditions studied
- Abdominal Hernia — all drugs for Abdominal Hernia →
Sponsor
Assiut University
Who can join
Adults 20 to 60, female only, with Abdominal Hernia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparison between hernioplasty alone versus concomitant abdominoplasty with ventral hernia repair regarding efficacy and post-operative recurrence of hernia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05792839
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Abdominal Hernia
Currently open trials in the same condition.
- NCT05906017 — Open Versus Robotic-assisted Ventral Hernia Repair, Short and Long-term Outcome · NA · active not recruiting
- NCT04578340 — Long Term Outcomes Following Hernia Repair With Mesh · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05792839 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 18 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05792839.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing